Viewing StudyNCT03190967



Ignite Creation Date: 2024-05-06 @ 10:12 AM
Last Modification Date: 2024-10-26 @ 12:26 PM
Study NCT ID: NCT03190967
Status: TERMINATED
Last Update Posted: 2023-10-11
First Post: 2017-06-16

Brief Title: T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic Radiosurgery
Sponsor: National Cancer Institute NCI
Organization: National Institutes of Health Clinical Center CC

Conditions & Keywords Data

Conditions:
Name
Brain Cancer
Breast Cancer
Brain Metastasis
Keywords:
Name View
Preventing the Formation of a Metastasis View
Ado-trastuzumab Emtansine View
Systemic Control of Disease View
Maximum Tolerated Dose View